Effect of tolvaptan on acute heart failure with hyponatremia – A randomized, double blind, controlled clinical trial

OBJECTIVES: To assess the efficacy of tolvaptan in acute heart failure with hyponatremia using a randomized double-blinded placebo-controlled study design. BACKGROUND: Tolvaptan is a selective vasopressin receptor 2 antagonist. There are no published clinical trials on the utility of tolvaptan in ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Shanmugam, Elangovan, Doss, C.R. Madhu Prabhu, George, Melvin, Jena, Amrita, Rajaram, Muthukumar, Ramaraj, Balaji, Anjaneyan, Karthik, Kanagesh, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824334/
https://www.ncbi.nlm.nih.gov/pubmed/27056648
http://dx.doi.org/10.1016/j.ihj.2015.07.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824334/
https://www.ncbi.nlm.nih.gov/pubmed/27056648
http://dx.doi.org/10.1016/j.ihj.2015.07.006

Ejemplares similares